Correlation Between Scpharmaceuticals and MediciNova

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and MediciNova, you can compare the effects of market volatilities on Scpharmaceuticals and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and MediciNova.

Diversification Opportunities for Scpharmaceuticals and MediciNova

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Scpharmaceuticals and MediciNova is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and MediciNova go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and MediciNova

Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the MediciNova. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 2.51 times less risky than MediciNova. The stock trades about -0.2 of its potential returns per unit of risk. The MediciNova is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  166.00  in MediciNova on August 26, 2024 and sell it today you would earn a total of  47.00  from holding MediciNova or generate 28.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Scpharmaceuticals  vs.  MediciNova

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
MediciNova 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Scpharmaceuticals and MediciNova Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and MediciNova

The main advantage of trading using opposite Scpharmaceuticals and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.
The idea behind Scpharmaceuticals and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum